Current strategies for early Hodgkin's disease

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Canellos, G R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Early stages; Hodgkin's disease; Prognostic factors; Therapy; Treatment options

Indexed keywords

BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HODGKIN DISEASE; HUMAN; LUNG TOXICITY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029798738     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.S91     Document Type: Conference Paper

References (23)

1. Tubiana M, Henry-Amar M, Carde P et al. Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 1989; 73:47-56.
2. Leibenhaut M, Hoppe R, Efron B et al. Prognostic indicators of laparotomy findings in clinical stage I-II supradiaphragmatic Hodgkin's disease. J Clin Oncol 1989; 7:81-91.
3. Mauch P, Larson D, Osteen R et al. Prognostic factors for positive surgical staging in patients with Hodgkin's disease. J Clin Oncol 1990; 8:257-65.
4. Canellos G, Anderson J, Propert K et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. New Engl J Med 1992; 327:1478-84.
5. Santoro A, Bonadonna G, Valagussa P et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: Superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 1987; 5:27-37.
6. Leopold K, Canellos G, Rosenthal D et al. Stage IA-IIB Hodgkin's disease: Staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol 1989; 7:1059-65.
7. Longo D, Russo A, Duffey P et al. Treatment of advancedstage massive mediastinal Hodgkin's disease: The case for combined modality treatment. J Clin Oncol 1991; 9:227-35.
8. Fabian C, Mansfield C, Dahlberg S et al. Low-dose involved field radiation after chemotherapy in advanced Hodgkin's disease. A Southwest Oncology Group randomized study. Ann Intern Med 1994; 120:903-12.
9. Preti A, Hagemeister F, McLaughlin P et al. Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches. Ann Oncol 1994; 5: S97-S100.
10. Yelle L, Bergsagel D, Basco V et al. Combined modality therapy of Hodgkin's disease: 10-Year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial. J Clin Oncol 1991; 9:1983-93.
11. Fuller L, Hagemeister F, North L et al. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: Preliminary results. Int J Radiat Oncol Biol Phys 1988; 14:683-92.
12. Eghbali H, Bonichon F, David B et al. Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: Analysis of a series of 94 patients. Radiother Oncol 1990; 18:127-36.
13. 2A: Results of a prospective clinical trial with 166 patients. Cancer 1980; 46:2126-30.
14. Anderson H, Crowther D, Deakin D et al. A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-Year follow-up. Ann Oncol 1991; 2 (Suppl 2): 49-54.
15. Straus D, Yaholom J, Gaynor J et al. Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease. Cancer 1992; 69: 1052-60.
16. Glimelius B, Kälkner M, Enblad et al. Treatment of early and intermediate stages of supradiaphragmatic Hodgkin's disease: The Swedish National Cancer Programme experience. Ann Oncol 1994; 5:809-16.
17. Horning S, Hoppe R, Hancock S et al. Vinblastine, bleomycin and methotrexate: An effective adjuvant in favorable Hodgkin's disease. J Clin Oncol 1988; 6:1822-31.
18. Bates N, Williams M, Bessell E et al. Efficacy and toxicity of vinblastine, bleomycin, and methotrexate \\ith involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: A British National Lymphoma Investigation pilot study. J Clin Oncol 1994; 12:288-96.
19. Horning S, Adhikari A, Rizk N et al. Effect of treatment for Hodgkin's disease on pulmonary function: Results of a prospective study. J Clin Oncol 1994; 12:297-305.
20. Canellos G, Petroni G, Barcos M et al. Etoposide, vinblastine, and doxorubicin: An active regimen for the treatment of Hodgkin's disease in relapse following MOPP. J Clin Oncol 1995; 13:2005-11.
21. Hagemeister F, Purugganan R, Fuller L et al. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy. Semin Hematol 1994; 31 (Suppl 3): 36-43.
22. Front D, Israel O. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Semin Nucl Med 1995; 25:60-71.
23. Pavlovsky S, Maschio M, Santarelli M et al. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage I-II Hodgkin's disease. J Natl Cancer Inst 1988; 80: 1466-73.